Stock NTLA INTELLIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Intellia Therapeutics, Inc.

Equities

NTLA

US45826J1051

Market Closed - Nasdaq
Other stock markets
 01:30:00 22/06/2024 am IST 		5-day change 1st Jan Change
24.22 USD +0.29% Intraday chart for Intellia Therapeutics, Inc. -3.70% -20.56%
17/06 Intellia Therapeutics to Present the First-Ever Clinical Data from Patients Redosed with an Investigational in Vivo CRISPR Gene Editing Therapy At the Peripheral Nerve Society Annual Meeting 2024 CI
14/06 Intellia Therapeutics, Inc. Names Brian Goff to its Board of Directors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
INTELLIA THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+0.29%-3.70%-20.56%-42.13%+64.43% 2.34B
Neutral
Neutral
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. NTLA Stock
  4. Charts Intellia Therapeutics, Inc.
  5. Comparison Chart